Correlation Between Palomar Holdings and DanCann Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Palomar Holdings and DanCann Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Palomar Holdings and DanCann Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Palomar Holdings and DanCann Pharma AS, you can compare the effects of market volatilities on Palomar Holdings and DanCann Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Palomar Holdings with a short position of DanCann Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Palomar Holdings and DanCann Pharma.

Diversification Opportunities for Palomar Holdings and DanCann Pharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Palomar and DanCann is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Palomar Holdings and DanCann Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DanCann Pharma AS and Palomar Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Palomar Holdings are associated (or correlated) with DanCann Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DanCann Pharma AS has no effect on the direction of Palomar Holdings i.e., Palomar Holdings and DanCann Pharma go up and down completely randomly.

Pair Corralation between Palomar Holdings and DanCann Pharma

If you would invest  4,973  in Palomar Holdings on September 26, 2024 and sell it today you would earn a total of  5,528  from holding Palomar Holdings or generate 111.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy79.1%
ValuesDaily Returns

Palomar Holdings  vs.  DanCann Pharma AS

 Performance 
       Timeline  
Palomar Holdings 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Palomar Holdings are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating primary indicators, Palomar Holdings may actually be approaching a critical reversion point that can send shares even higher in January 2025.
DanCann Pharma AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days DanCann Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, DanCann Pharma is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Palomar Holdings and DanCann Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Palomar Holdings and DanCann Pharma

The main advantage of trading using opposite Palomar Holdings and DanCann Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Palomar Holdings position performs unexpectedly, DanCann Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DanCann Pharma will offset losses from the drop in DanCann Pharma's long position.
The idea behind Palomar Holdings and DanCann Pharma AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities